Novartis Ag ADR
(NVS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 56,674,000 | 51,722,000 | 46,660,000 | 43,461,000 | 52,877,000 |
| Cost of Goods | 13,699,000 | 12,827,000 | 12,472,000 | 11,582,000 | 15,867,000 |
| Gross Profit | 42,975,000 | 38,895,000 | 34,188,000 | 31,879,000 | 37,010,000 |
| Operating Expenses | 25,331,000 | 24,351,000 | 24,419,000 | 23,933,000 | 25,321,000 |
| Operating Income | 17,644,000 | 14,544,000 | 9,769,000 | 7,946,000 | 11,689,000 |
| Interest Expense | 1,144,000 | 1,006,000 | 855,000 | 800,000 | 811,000 |
| Other Income | -148,000 | 102,000 | 209,000 | 31,000 | 15,259,000 |
| Pre-tax Income | 16,352,000 | 13,640,000 | 9,123,000 | 7,177,000 | 26,137,000 |
| Income Tax | 2,385,000 | 1,701,000 | 551,000 | 1,128,000 | 2,119,000 |
| Net Income Continuous | 13,967,000 | 11,939,000 | 8,572,000 | 6,049,000 | 24,018,000 |
| Net Income Discontinuous | N/A | N/A | 6,282,000 | 906,000 | N/A |
| Minority Interests | -17,000 | -2,000 | 4,000 | 0 | -3,000 |
| Net Income | $13,984,000 | $11,941,000 | $14,850,000 | $6,955,000 | $24,021,000 |
| EPS Basic Total Ops | 7.21 | 5.92 | 7.15 | 3.19 | 10.71 |
| EPS Basic Continuous Ops | 7.20 | 5.92 | 4.13 | 2.77 | 10.71 |
| EPS Basic Discontinuous Ops | N/A | N/A | 3.02 | 0.42 | N/A |
| EPS Diluted Total Ops | 7.15 | 5.87 | 7.10 | 3.17 | 10.63 |
| EPS Diluted Continuous Ops | 7.14 | 5.87 | 4.10 | 2.75 | 10.63 |
| EPS Diluted Discontinuous Ops | N/A | N/A | 3.00 | 0.41 | N/A |
| EPS Diluted Before Non-Recurring Items | N/A | 7.81 | 6.90 | 6.10 | 6.24 |
| EBITDA(a) | $22,919,000 | $20,658,000 | $18,152,000 | $14,911,000 | $11,689,000 |